pediatric hypertension 3rd edition
Pediatric Hypertension, 3rd Edition
$150.00 Original price was: $150.00.$4.99Current price is: $4.99. Add to cart
Sale!

Pediatric Hypertension, 3rd Edition

Original price was: $150.00.Current price is: $4.99.

-97%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

Combating a Silent Epidemic: Pediatric Hypertension (3rd Edition)

High blood pressure is no longer exclusively a disease of aging adults; it is a terrifying, silent epidemic rapidly destroying the cardiovascular systems of children and adolescents. Pediatric Hypertension (3rd Edition) is the definitive, fiercely specialized medical encyclopedia dedicated entirely to this crisis. For pediatric nephrologists, cardiologists, and primary care physicians, this massive volume provides the absolute, uncompromising blueprints required to diagnose, investigate, and aggressively treat high blood pressure before it causes irreversible organ damage.

The Alarming Rise of High Blood Pressure in Children

The core philosophy of this text is that pediatric hypertension is a high-stakes, multi-system threat. The authors aggressively deconstruct the changing epidemiology of the disease, driven largely by the global pediatric obesity crisis. They detail exactly how chronic high blood pressure quietly damages the pediatric heart (causing left ventricular hypertrophy) and the kidneys, demanding that physicians take every elevated reading with absolute seriousness.

Complex Diagnostic Criteria and Ambulatory Monitoring

The book provides a masterclass in advanced diagnostic precision. Diagnosing hypertension in a child is infinitely more complex than in an adult. The text dictates the exact, rigid percentile charts (based on age, sex, and height) required to confirm the diagnosis. Furthermore, it provides exhaustive protocols for Ambulatory Blood Pressure Monitoring (ABPM), ensuring physicians can definitively rule out “white coat hypertension” before prescribing powerful medications.

Differentiating Primary vs. Secondary Hypertension

This is a fiercely analytical guide to medical investigation. In young children, hypertension is almost always a symptom of a catastrophic underlying disease. The authors provide the exact diagnostic algorithms required to hunt down secondary causes. They detail exactly how to investigate for renal artery stenosis, severe parenchymal kidney disease, and complex endocrine tumors (like pheochromocytoma) that drive lethal blood pressure spikes.

Aggressive Pharmacological Management Protocols

The final value of this reference is its absolute focus on therapeutic intervention. When lifestyle modifications fail, pharmacological control is mandatory to prevent stroke and heart failure. The text provides the exact, weight-based (mg/kg) dosing regimens for ACE inhibitors, calcium channel blockers, and beta-blockers in children. It dictates exactly how to safely titrate these drugs to achieve target blood pressures without causing severe hypotension.

Frequently Asked Questions (FAQs)

Does this cover neonatal hypertension?
Yes, it includes highly specialized, critical sections on managing severe hypertension in the Neonatal Intensive Care Unit (NICU), often caused by umbilical artery catheter complications or congenital renal disease.

Are the latest AAP guidelines included?
Absolutely. The text comprehensively integrates and expands upon the latest clinical practice guidelines for screening and managing high blood pressure in children.

Who is the primary audience?
It is the absolute, undisputed, mandatory desk reference for Pediatric Nephrologists, Pediatric Cardiologists, Pediatric Intensivists, and General Pediatricians managing complex patients.

Conclusion

Pediatric Hypertension (3rd Edition) proves that managing high blood pressure in children requires immense diagnostic rigor and pharmacological precision. It is an indispensable tool for the sub-specialty clinic. By mastering the complex ABPM protocols, the rigid investigational algorithms, and the aggressive pharmacological interventions detailed in this volume, physicians can halt this silent epidemic and protect the future of their patients’ hearts and kidneys.